SlideShare a Scribd company logo
HIV/AIDS TREATMENT:
ROLE OF DIFFERENT
MEDICINAL SYTEM
By
Mrs. S. Gomathi., M.Pharm., (Ph. D)
Assistant Professor
Department of Pharmaceutical Chemistry
JKK Nattraja College of Pharmacy
Kumarapalayam 638183
DISTRICT-WISE SCENARIO OF AIDS
Category NACP-III
A 156
B 39
C 296
D 118
New Districts 30
Total 609
4
Category NACP-III Definition
A > 1% ANC prevalence in any of the sites in
the last 3 years
B < 1% ANC prevalence in all the sites during
last 3 years with > 5% prevalence in any
HRG site (STD/FSW/MSM/IDU)
C < 1% ANC prevalence in all sites during last
3 years with < 5% in all STD clinic
attendees or any HRG, with known hot
spots
D < 1% ANC prevalence in all sites during last
3 years with < 5% in all STD clinic
attendees or any HRG OR no or poor HIV
data with no known hot spots
What is HIV/AIDS?
HIV means Human
immunodeficiency virus
while AIDS means Acquired
Immunodeficiency
Syndrome –It’s a disease of
the human immune system
caused by the human
immunodeficiency virus
(HIV).
6
How Do You Get HIV/AIDS?
SYMPTOMS AND SIGNS OF HIV
The most common symptoms of primary HIV infection are:
• fever,
• aching muscles and joints,
• sore throat and
• swollen glands (lymph nodes) in the neck.
• Ulcers in the mouth
Swollen parts of the body
Deterioration of the body tissues
Effects of HIV/AIDS
TESTING OPTIONS FOR HIV
Administration
• Blood
• Urine
• Oral
13
BLOOD DETECTION TESTS
• Enzyme-Linked Immunosorbent Assay/Enzyme
Immunoassay (ELISA/EIA)
• Radio Immunoprecipitation Assay/Indirect
Fluorescent Antibody Assay (RIP/IFA)
• Polymerase Chain Reaction (PCR)
• Western Blot Confirmatory test
14
URINE TESTING
• Urine Western Blot
– As sensitive as testing blood
– Safe way to screen for HIV
– Can cause false positives in
certain people at high risk for
HIV
15
ORAL TESTING
• Orasure
– The only FDA approved HIV
antibody.
– As accurate as blood
testing
– Draws blood-derived fluids
from the gum tissue.
– NOT A SALIVA TEST!
16
PREVENTION OF HIV/AIDS
CLASSIFICATION OF
ANTIRETROVIRAL MEDICINES
• NRTI (Nucleoside Reverse Transcriptase Inhibitors)
• NtRTI (Nucleotide Reverse Transcriptase Inhibitors)
• NNRTI ( Non-Nucleoside Reverse Transcriptase
Inhibitors)
• PI (Protease Inhibitors)
• Other ARVs
• Entry Inhibitors: Fusion Inhibitor: Enfuvirtide.
Penitration blockrs: Maraviroc
• Integrase inhibitors: Raltegravir, Elvitegravir
• Maturation inhibitors: Beviramat
19
PROTEASE INHIBITORS (PIS)
Agent Approved Dose frequency
Saquinavir -HGC 12/95 1000mg
(500mg)
BID
Ritonavir 3/96 300mg,600mg BID
Indinavir 3/96 800mg TID
Nelfinavir 3/97 750mg
1250mg
TID
BID
Saquinavir-SGC 11/97 1000mg BID
Lopinavir/ritonavir 9/2000 400mg/100mg BID
Atazanavir 6/03 400mg OD
Fosamprenavir 10/03 1400mg BID
Tipranavir 6/05 500mg BID
Darunavir 6/06 600mg BID
20
HERBAL DRUGS (AYURVEDHA,SIDDHA)-
POSSIBLE ROLE IN TREATMENT OF HIV
Withania somifera , Mangifera indica, Allium sativum, Hypericum
perforatum.
Rasayana reported to exert immunomodulatory effects include
Aloe vera, Asparagus racemosus, Boerhavia diffusa, Piper
longum.
The Non-Rasayana Plants with immunomodulatory effects
include Andrographis paniculata, Banksia serrata,Centella
asiatica, Curcuma longa and Tamarindus indica.
Ayurvedic medicines used for HIV patients include
'Chyavanprash', and 'Raktavardhak' for immunity
building and 'Sookshma triphla tabs' to prevent
infection.
METHODS OF CONTROL
Preventive measures:
• Refraining from unprotected Intercourse.
• Refraining from intravenous drug use.
• People who have HIV infection should not donate
plasma, blood, organs for transplantation, tissue or cells.
• All pregnant women must be counselled about HIV early
in pregnancy and encouraged to undertake an HIV test
as a routine part of standard antenatal care.
• Those found to be HIV-positive take a course of ARV
treatment, to reduce the risk of their infant being
infected. 23
METHODS OF CONTROL (CONT.)
• Care must be taken in handling, using and disposing of
needles or other sharp instruments.
• WHO recommends immunization of asymptomatic
HIVinfected children with the EPI vaccines; those who
are symptomatic should not receive BCG vaccine.
• Live Measles-Mumps-Rubella and polio vaccines are
recommended for all HIV-infected children.
• HIV testing and counselling is an important intervention
for raising awareness of HIV status, promoting
behavioural change and diagnosing HIV infection.
24
CONCLUSION
• HIV/AIDS is a world epidemic. Although making new
advances in combating this virus, there are many new
infections every year. All should know what how it spreads
and how to prevent it. Should take a HIV/AIDS test if involved
in any risky behaviors. And also should tell others the
importance of getting tested and prevention.
• Finally, partnerships between the allopathic and traditional,
complementary health sectors in research, policy, and
practice are essential in building comprehensive AIDS
treatment strategies. Policies that increase the collaboration
between these two care sectors should be strongly
encouraged.
25
REFERENCES
Pharmacotherapy, A Pathophysiologic approach by J.T.Dipiro 8 th
edition, page.no:2065-2081
emedicine.medscape.com/article/1533218-Author R Chris Rathbun
 Aberg, J. A., Kaplan, J. E., Libman, H., "Primary Care Guidelines for
the Management of Persons Infected with Human
Immunodeficiency Virus: 2009 Update by the HIV Medicine
Association of the Infectious Diseases Society of America.
 Book of MEDICINE 4th edition, Authors K George Mathew, Praveen
Aggarwal, Pg.no.223-234 Anti Retroviral therapy.
HIV

More Related Content

What's hot

Dr. Chris Vinnard's 2013 HIV Treatment Update
Dr. Chris Vinnard's 2013 HIV Treatment UpdateDr. Chris Vinnard's 2013 HIV Treatment Update
Dr. Chris Vinnard's 2013 HIV Treatment Update
Office of HIV Planning
 
HAART
HAART HAART
HAART
Ankit Gupta
 
Treatment of hcv_in_hiv_infected_patients
Treatment of hcv_in_hiv_infected_patientsTreatment of hcv_in_hiv_infected_patients
Treatment of hcv_in_hiv_infected_patients
NAIF AL SAGLAN
 
Hepatitis c treatment in ESRD patients , update Dr Ayman Seddik
Hepatitis c treatment in ESRD patients , update  Dr Ayman Seddik  Hepatitis c treatment in ESRD patients , update  Dr Ayman Seddik
Hepatitis c treatment in ESRD patients , update Dr Ayman Seddik
Ayman Seddik
 
Advances in hiv treatment
Advances in hiv treatmentAdvances in hiv treatment
Advances in hiv treatment
Chandan N
 
HCV guidance may_24_2018b
HCV guidance may_24_2018bHCV guidance may_24_2018b
HCV guidance may_24_2018b
Dr. Afzal Haq Asif
 
Hepatitis c new guidelines 2014 by aasld idsa sofosbuvir
Hepatitis c new guidelines 2014 by aasld idsa sofosbuvirHepatitis c new guidelines 2014 by aasld idsa sofosbuvir
Hepatitis c new guidelines 2014 by aasld idsa sofosbuvir
Muhammad Farooq
 
Hepitits c
Hepitits cHepitits c
Hepitits c
Mushahid Hasan
 
Hepatitis C Treatment Questions
Hepatitis C Treatment QuestionsHepatitis C Treatment Questions
Hepatitis C Treatment Questions
Jenny Chan
 
HAART
HAARTHAART
HAART
Dr Ashish
 
Hepatitis C Infection Anand Medicos
Hepatitis C Infection Anand MedicosHepatitis C Infection Anand Medicos
Hepatitis C Infection Anand Medicos
Anand Medicos
 
Highly active antiretroviral therapy
Highly active antiretroviral therapyHighly active antiretroviral therapy
Highly active antiretroviral therapy
Abhishek Gupta
 
HCV management, guidelines 2016
HCV management, guidelines 2016HCV management, guidelines 2016
HCV management, guidelines 2016
Usama Ragab
 
Hepatitis C presentation by CADTH
Hepatitis C presentation by CADTHHepatitis C presentation by CADTH
Hepatitis C presentation by CADTH
PASaskatchewan
 
Highly active antiretroviral therapy incidence of adverse drug reactions
Highly active antiretroviral therapy incidence of adverse drug reactionsHighly active antiretroviral therapy incidence of adverse drug reactions
Highly active antiretroviral therapy incidence of adverse drug reactions
pharmaindexing
 
Hcv presentation
Hcv presentationHcv presentation
Hcv presentation
doczia
 
Easl recommendations on the treatment of Hepatitis C
Easl recommendations on the treatment of Hepatitis CEasl recommendations on the treatment of Hepatitis C
Easl recommendations on the treatment of Hepatitis C
West Medicine Ward
 
Sofosbuvir ppt
Sofosbuvir pptSofosbuvir ppt
Sofosbuvir ppt
Dr dipankar das
 
Clinical aspects of hepatitis e virus infection
Clinical aspects of hepatitis e virus infectionClinical aspects of hepatitis e virus infection
Clinical aspects of hepatitis e virus infection
Cornelia Adlhoch
 
Treatment of HCV Genotype 4
Treatment of HCV Genotype 4Treatment of HCV Genotype 4
Treatment of HCV Genotype 4
Mahmoud Elzalabany
 

What's hot (20)

Dr. Chris Vinnard's 2013 HIV Treatment Update
Dr. Chris Vinnard's 2013 HIV Treatment UpdateDr. Chris Vinnard's 2013 HIV Treatment Update
Dr. Chris Vinnard's 2013 HIV Treatment Update
 
HAART
HAART HAART
HAART
 
Treatment of hcv_in_hiv_infected_patients
Treatment of hcv_in_hiv_infected_patientsTreatment of hcv_in_hiv_infected_patients
Treatment of hcv_in_hiv_infected_patients
 
Hepatitis c treatment in ESRD patients , update Dr Ayman Seddik
Hepatitis c treatment in ESRD patients , update  Dr Ayman Seddik  Hepatitis c treatment in ESRD patients , update  Dr Ayman Seddik
Hepatitis c treatment in ESRD patients , update Dr Ayman Seddik
 
Advances in hiv treatment
Advances in hiv treatmentAdvances in hiv treatment
Advances in hiv treatment
 
HCV guidance may_24_2018b
HCV guidance may_24_2018bHCV guidance may_24_2018b
HCV guidance may_24_2018b
 
Hepatitis c new guidelines 2014 by aasld idsa sofosbuvir
Hepatitis c new guidelines 2014 by aasld idsa sofosbuvirHepatitis c new guidelines 2014 by aasld idsa sofosbuvir
Hepatitis c new guidelines 2014 by aasld idsa sofosbuvir
 
Hepitits c
Hepitits cHepitits c
Hepitits c
 
Hepatitis C Treatment Questions
Hepatitis C Treatment QuestionsHepatitis C Treatment Questions
Hepatitis C Treatment Questions
 
HAART
HAARTHAART
HAART
 
Hepatitis C Infection Anand Medicos
Hepatitis C Infection Anand MedicosHepatitis C Infection Anand Medicos
Hepatitis C Infection Anand Medicos
 
Highly active antiretroviral therapy
Highly active antiretroviral therapyHighly active antiretroviral therapy
Highly active antiretroviral therapy
 
HCV management, guidelines 2016
HCV management, guidelines 2016HCV management, guidelines 2016
HCV management, guidelines 2016
 
Hepatitis C presentation by CADTH
Hepatitis C presentation by CADTHHepatitis C presentation by CADTH
Hepatitis C presentation by CADTH
 
Highly active antiretroviral therapy incidence of adverse drug reactions
Highly active antiretroviral therapy incidence of adverse drug reactionsHighly active antiretroviral therapy incidence of adverse drug reactions
Highly active antiretroviral therapy incidence of adverse drug reactions
 
Hcv presentation
Hcv presentationHcv presentation
Hcv presentation
 
Easl recommendations on the treatment of Hepatitis C
Easl recommendations on the treatment of Hepatitis CEasl recommendations on the treatment of Hepatitis C
Easl recommendations on the treatment of Hepatitis C
 
Sofosbuvir ppt
Sofosbuvir pptSofosbuvir ppt
Sofosbuvir ppt
 
Clinical aspects of hepatitis e virus infection
Clinical aspects of hepatitis e virus infectionClinical aspects of hepatitis e virus infection
Clinical aspects of hepatitis e virus infection
 
Treatment of HCV Genotype 4
Treatment of HCV Genotype 4Treatment of HCV Genotype 4
Treatment of HCV Genotype 4
 

Viewers also liked

NEURODEGENERATIVE DISEASES
NEURODEGENERATIVE DISEASESNEURODEGENERATIVE DISEASES
NEURODEGENERATIVE DISEASES
Gomathi .S
 
Neurodegenerative disorder
Neurodegenerative disorderNeurodegenerative disorder
Neurodegenerative disorder
Satish Tadakanahalli
 
popular games in india
popular games in indiapopular games in india
popular games in india
SHANTY E V E V
 
Is cloud computing right for your business
Is cloud computing right for your businessIs cloud computing right for your business
Is cloud computing right for your business
Tyrone Systems
 
Búsqueda en scopus y cinahl
Búsqueda en scopus y cinahlBúsqueda en scopus y cinahl
Búsqueda en scopus y cinahl
Inmaculada Martín Varo
 
Task 2
Task 2Task 2
3Com 3C10318
3Com 3C103183Com 3C10318
3Com 3C10318
savomir
 
Apresentação Konnecta TI Consultoria
Apresentação Konnecta TI ConsultoriaApresentação Konnecta TI Consultoria
Apresentação Konnecta TI Consultoria
Gilberto Nunes
 
smjestajni kapaciteti Rijeke
smjestajni kapaciteti Rijekesmjestajni kapaciteti Rijeke
smjestajni kapaciteti Rijeke
Mauro Ćiković
 
Gudi Padwa 2017
Gudi Padwa 2017Gudi Padwa 2017
Gudi Padwa 2017
Swati1223
 
12 2 chords and arcs concepts
12 2 chords and arcs concepts12 2 chords and arcs concepts
12 2 chords and arcs concepts
LomasGeomConc16
 
Favorite food France
Favorite food FranceFavorite food France
Favorite food France
EcoleArencBachas
 
Higiene y seguridad indusrtial
Higiene y seguridad indusrtialHigiene y seguridad indusrtial
Higiene y seguridad indusrtial
daniel acosta cubides
 
Valeria
ValeriaValeria
Didáctica crítica.
Didáctica crítica. Didáctica crítica.
Didáctica crítica.
Viridiana Ambrosio Alcantara
 
LE & TRAN. Diagram. Cases of Termination of Labor Contract
LE & TRAN. Diagram. Cases of Termination of Labor ContractLE & TRAN. Diagram. Cases of Termination of Labor Contract
LE & TRAN. Diagram. Cases of Termination of Labor Contract
LE & TRAN | Trial Lawyers
 
Auto approve dofollow blog commenting sites for backlinks my techgoal
Auto approve dofollow blog commenting sites for backlinks   my techgoalAuto approve dofollow blog commenting sites for backlinks   my techgoal
Auto approve dofollow blog commenting sites for backlinks my techgoal
Munna Hossain
 
Diapositivas uml
Diapositivas umlDiapositivas uml
Diapositivas uml
jose valencia
 

Viewers also liked (18)

NEURODEGENERATIVE DISEASES
NEURODEGENERATIVE DISEASESNEURODEGENERATIVE DISEASES
NEURODEGENERATIVE DISEASES
 
Neurodegenerative disorder
Neurodegenerative disorderNeurodegenerative disorder
Neurodegenerative disorder
 
popular games in india
popular games in indiapopular games in india
popular games in india
 
Is cloud computing right for your business
Is cloud computing right for your businessIs cloud computing right for your business
Is cloud computing right for your business
 
Búsqueda en scopus y cinahl
Búsqueda en scopus y cinahlBúsqueda en scopus y cinahl
Búsqueda en scopus y cinahl
 
Task 2
Task 2Task 2
Task 2
 
3Com 3C10318
3Com 3C103183Com 3C10318
3Com 3C10318
 
Apresentação Konnecta TI Consultoria
Apresentação Konnecta TI ConsultoriaApresentação Konnecta TI Consultoria
Apresentação Konnecta TI Consultoria
 
smjestajni kapaciteti Rijeke
smjestajni kapaciteti Rijekesmjestajni kapaciteti Rijeke
smjestajni kapaciteti Rijeke
 
Gudi Padwa 2017
Gudi Padwa 2017Gudi Padwa 2017
Gudi Padwa 2017
 
12 2 chords and arcs concepts
12 2 chords and arcs concepts12 2 chords and arcs concepts
12 2 chords and arcs concepts
 
Favorite food France
Favorite food FranceFavorite food France
Favorite food France
 
Higiene y seguridad indusrtial
Higiene y seguridad indusrtialHigiene y seguridad indusrtial
Higiene y seguridad indusrtial
 
Valeria
ValeriaValeria
Valeria
 
Didáctica crítica.
Didáctica crítica. Didáctica crítica.
Didáctica crítica.
 
LE & TRAN. Diagram. Cases of Termination of Labor Contract
LE & TRAN. Diagram. Cases of Termination of Labor ContractLE & TRAN. Diagram. Cases of Termination of Labor Contract
LE & TRAN. Diagram. Cases of Termination of Labor Contract
 
Auto approve dofollow blog commenting sites for backlinks my techgoal
Auto approve dofollow blog commenting sites for backlinks   my techgoalAuto approve dofollow blog commenting sites for backlinks   my techgoal
Auto approve dofollow blog commenting sites for backlinks my techgoal
 
Diapositivas uml
Diapositivas umlDiapositivas uml
Diapositivas uml
 

Similar to HIV

Hiv.
Hiv.Hiv.
haart-170422040325.pdf
haart-170422040325.pdfhaart-170422040325.pdf
haart-170422040325.pdf
FadilaLawal
 
haart-170422040325.pdf
haart-170422040325.pdfhaart-170422040325.pdf
haart-170422040325.pdf
FadilaLawal
 
Sexually Transmitted Infections Update
Sexually Transmitted Infections UpdateSexually Transmitted Infections Update
Sexually Transmitted Infections Update
UC San Diego AntiViral Research Center
 
UPDATED MED LONG TERM
UPDATED MED LONG TERMUPDATED MED LONG TERM
UPDATED MED LONG TERM
Danielle Gill
 
Clinical Impact of New HIV Data From CROI 2019
Clinical Impact of New HIV Data From CROI 2019Clinical Impact of New HIV Data From CROI 2019
Clinical Impact of New HIV Data From CROI 2019
hivlifeinfo
 
Can we end the HIV/AIDS epidemic? Josip begovac
Can we end the HIV/AIDS epidemic? Josip begovacCan we end the HIV/AIDS epidemic? Josip begovac
Can we end the HIV/AIDS epidemic? Josip begovac
PinHealth
 
NYSDOH AI Management of Gonorrhea and Chlamydia in Patients with HIV
NYSDOH AI Management of Gonorrhea and Chlamydia in Patients with HIVNYSDOH AI Management of Gonorrhea and Chlamydia in Patients with HIV
NYSDOH AI Management of Gonorrhea and Chlamydia in Patients with HIV
HIV Clinical Guidelines Program
 
Imoudu
ImouduImoudu
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
StopTb Italia
 
current hiv situation in india and national aids control programme an overview
current hiv situation in india and national aids control programme an overviewcurrent hiv situation in india and national aids control programme an overview
current hiv situation in india and national aids control programme an overview
ikramdr01
 
Prevention and control of aids
Prevention and control of aidsPrevention and control of aids
Prevention and control of aids
Afreenusmani
 
Hiv basic concept
Hiv basic conceptHiv basic concept
Hiv basic concept
DwiKartikaRukmi
 
Epidemiology of HIV & AIDS.pptx presentation 2024
Epidemiology of HIV & AIDS.pptx presentation 2024Epidemiology of HIV & AIDS.pptx presentation 2024
Epidemiology of HIV & AIDS.pptx presentation 2024
Motahar Alam
 
Hiv and periodontium
Hiv and periodontiumHiv and periodontium
Hiv and periodontium
Dandu Prasad Reddy
 
Antimicrobial Stewardship and Applications to Common Infections
Antimicrobial Stewardship and Applications to Common InfectionsAntimicrobial Stewardship and Applications to Common Infections
Antimicrobial Stewardship and Applications to Common Infections
PASaskatchewan
 
Hiv recent guidelines naco 2015
Hiv recent guidelines naco 2015Hiv recent guidelines naco 2015
Hiv recent guidelines naco 2015
Mehakinder Singh
 
Prevention of Hepatitis B & C in Haemodialysis Patients
Prevention of Hepatitis B & C in Haemodialysis PatientsPrevention of Hepatitis B & C in Haemodialysis Patients
Prevention of Hepatitis B & C in Haemodialysis Patients
Kazi Mahmudul Haque
 
National HIV testing and treatment guidelines
National HIV testing and treatment guidelines National HIV testing and treatment guidelines
National HIV testing and treatment guidelines
BISHAL SAPKOTA
 
RECENT RETROVIRAL DISEAAE GUIDELINES
RECENT RETROVIRAL DISEAAE GUIDELINESRECENT RETROVIRAL DISEAAE GUIDELINES
RECENT RETROVIRAL DISEAAE GUIDELINES
Ashutosh Pakale
 

Similar to HIV (20)

Hiv.
Hiv.Hiv.
Hiv.
 
haart-170422040325.pdf
haart-170422040325.pdfhaart-170422040325.pdf
haart-170422040325.pdf
 
haart-170422040325.pdf
haart-170422040325.pdfhaart-170422040325.pdf
haart-170422040325.pdf
 
Sexually Transmitted Infections Update
Sexually Transmitted Infections UpdateSexually Transmitted Infections Update
Sexually Transmitted Infections Update
 
UPDATED MED LONG TERM
UPDATED MED LONG TERMUPDATED MED LONG TERM
UPDATED MED LONG TERM
 
Clinical Impact of New HIV Data From CROI 2019
Clinical Impact of New HIV Data From CROI 2019Clinical Impact of New HIV Data From CROI 2019
Clinical Impact of New HIV Data From CROI 2019
 
Can we end the HIV/AIDS epidemic? Josip begovac
Can we end the HIV/AIDS epidemic? Josip begovacCan we end the HIV/AIDS epidemic? Josip begovac
Can we end the HIV/AIDS epidemic? Josip begovac
 
NYSDOH AI Management of Gonorrhea and Chlamydia in Patients with HIV
NYSDOH AI Management of Gonorrhea and Chlamydia in Patients with HIVNYSDOH AI Management of Gonorrhea and Chlamydia in Patients with HIV
NYSDOH AI Management of Gonorrhea and Chlamydia in Patients with HIV
 
Imoudu
ImouduImoudu
Imoudu
 
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
 
current hiv situation in india and national aids control programme an overview
current hiv situation in india and national aids control programme an overviewcurrent hiv situation in india and national aids control programme an overview
current hiv situation in india and national aids control programme an overview
 
Prevention and control of aids
Prevention and control of aidsPrevention and control of aids
Prevention and control of aids
 
Hiv basic concept
Hiv basic conceptHiv basic concept
Hiv basic concept
 
Epidemiology of HIV & AIDS.pptx presentation 2024
Epidemiology of HIV & AIDS.pptx presentation 2024Epidemiology of HIV & AIDS.pptx presentation 2024
Epidemiology of HIV & AIDS.pptx presentation 2024
 
Hiv and periodontium
Hiv and periodontiumHiv and periodontium
Hiv and periodontium
 
Antimicrobial Stewardship and Applications to Common Infections
Antimicrobial Stewardship and Applications to Common InfectionsAntimicrobial Stewardship and Applications to Common Infections
Antimicrobial Stewardship and Applications to Common Infections
 
Hiv recent guidelines naco 2015
Hiv recent guidelines naco 2015Hiv recent guidelines naco 2015
Hiv recent guidelines naco 2015
 
Prevention of Hepatitis B & C in Haemodialysis Patients
Prevention of Hepatitis B & C in Haemodialysis PatientsPrevention of Hepatitis B & C in Haemodialysis Patients
Prevention of Hepatitis B & C in Haemodialysis Patients
 
National HIV testing and treatment guidelines
National HIV testing and treatment guidelines National HIV testing and treatment guidelines
National HIV testing and treatment guidelines
 
RECENT RETROVIRAL DISEAAE GUIDELINES
RECENT RETROVIRAL DISEAAE GUIDELINESRECENT RETROVIRAL DISEAAE GUIDELINES
RECENT RETROVIRAL DISEAAE GUIDELINES
 

Recently uploaded

23PH301 - Optics - Optical Lenses.pptx
23PH301 - Optics  -  Optical Lenses.pptx23PH301 - Optics  -  Optical Lenses.pptx
23PH301 - Optics - Optical Lenses.pptx
RDhivya6
 
Sexuality - Issues, Attitude and Behaviour - Applied Social Psychology - Psyc...
Sexuality - Issues, Attitude and Behaviour - Applied Social Psychology - Psyc...Sexuality - Issues, Attitude and Behaviour - Applied Social Psychology - Psyc...
Sexuality - Issues, Attitude and Behaviour - Applied Social Psychology - Psyc...
PsychoTech Services
 
在线办理(salfor毕业证书)索尔福德大学毕业证毕业完成信一模一样
在线办理(salfor毕业证书)索尔福德大学毕业证毕业完成信一模一样在线办理(salfor毕业证书)索尔福德大学毕业证毕业完成信一模一样
在线办理(salfor毕业证书)索尔福德大学毕业证毕业完成信一模一样
vluwdy49
 
Sciences of Europe journal No 142 (2024)
Sciences of Europe journal No 142 (2024)Sciences of Europe journal No 142 (2024)
Sciences of Europe journal No 142 (2024)
Sciences of Europe
 
Modelo de slide quimica para powerpoint
Modelo  de slide quimica para powerpointModelo  de slide quimica para powerpoint
Modelo de slide quimica para powerpoint
Karen593256
 
Randomised Optimisation Algorithms in DAPHNE
Randomised Optimisation Algorithms in DAPHNERandomised Optimisation Algorithms in DAPHNE
Randomised Optimisation Algorithms in DAPHNE
University of Maribor
 
Mending Clothing to Support Sustainable Fashion_CIMaR 2024.pdf
Mending Clothing to Support Sustainable Fashion_CIMaR 2024.pdfMending Clothing to Support Sustainable Fashion_CIMaR 2024.pdf
Mending Clothing to Support Sustainable Fashion_CIMaR 2024.pdf
Selcen Ozturkcan
 
Juaristi, Jon. - El canon espanol. El legado de la cultura española a la civi...
Juaristi, Jon. - El canon espanol. El legado de la cultura española a la civi...Juaristi, Jon. - El canon espanol. El legado de la cultura española a la civi...
Juaristi, Jon. - El canon espanol. El legado de la cultura española a la civi...
frank0071
 
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
Sérgio Sacani
 
Gadgets for management of stored product pests_Dr.UPR.pdf
Gadgets for management of stored product pests_Dr.UPR.pdfGadgets for management of stored product pests_Dr.UPR.pdf
Gadgets for management of stored product pests_Dr.UPR.pdf
PirithiRaju
 
The cost of acquiring information by natural selection
The cost of acquiring information by natural selectionThe cost of acquiring information by natural selection
The cost of acquiring information by natural selection
Carl Bergstrom
 
快速办理(UAM毕业证书)马德里自治大学毕业证学位证一模一样
快速办理(UAM毕业证书)马德里自治大学毕业证学位证一模一样快速办理(UAM毕业证书)马德里自治大学毕业证学位证一模一样
快速办理(UAM毕业证书)马德里自治大学毕业证学位证一模一样
hozt8xgk
 
Authoring a personal GPT for your research and practice: How we created the Q...
Authoring a personal GPT for your research and practice: How we created the Q...Authoring a personal GPT for your research and practice: How we created the Q...
Authoring a personal GPT for your research and practice: How we created the Q...
Leonel Morgado
 
Describing and Interpreting an Immersive Learning Case with the Immersion Cub...
Describing and Interpreting an Immersive Learning Case with the Immersion Cub...Describing and Interpreting an Immersive Learning Case with the Immersion Cub...
Describing and Interpreting an Immersive Learning Case with the Immersion Cub...
Leonel Morgado
 
Micronuclei test.M.sc.zoology.fisheries.
Micronuclei test.M.sc.zoology.fisheries.Micronuclei test.M.sc.zoology.fisheries.
Micronuclei test.M.sc.zoology.fisheries.
Aditi Bajpai
 
ESR spectroscopy in liquid food and beverages.pptx
ESR spectroscopy in liquid food and beverages.pptxESR spectroscopy in liquid food and beverages.pptx
ESR spectroscopy in liquid food and beverages.pptx
PRIYANKA PATEL
 
Pests of Storage_Identification_Dr.UPR.pdf
Pests of Storage_Identification_Dr.UPR.pdfPests of Storage_Identification_Dr.UPR.pdf
Pests of Storage_Identification_Dr.UPR.pdf
PirithiRaju
 
waterlessdyeingtechnolgyusing carbon dioxide chemicalspdf
waterlessdyeingtechnolgyusing carbon dioxide chemicalspdfwaterlessdyeingtechnolgyusing carbon dioxide chemicalspdf
waterlessdyeingtechnolgyusing carbon dioxide chemicalspdf
LengamoLAppostilic
 
Basics of crystallography, crystal systems, classes and different forms
Basics of crystallography, crystal systems, classes and different formsBasics of crystallography, crystal systems, classes and different forms
Basics of crystallography, crystal systems, classes and different forms
MaheshaNanjegowda
 
The binding of cosmological structures by massless topological defects
The binding of cosmological structures by massless topological defectsThe binding of cosmological structures by massless topological defects
The binding of cosmological structures by massless topological defects
Sérgio Sacani
 

Recently uploaded (20)

23PH301 - Optics - Optical Lenses.pptx
23PH301 - Optics  -  Optical Lenses.pptx23PH301 - Optics  -  Optical Lenses.pptx
23PH301 - Optics - Optical Lenses.pptx
 
Sexuality - Issues, Attitude and Behaviour - Applied Social Psychology - Psyc...
Sexuality - Issues, Attitude and Behaviour - Applied Social Psychology - Psyc...Sexuality - Issues, Attitude and Behaviour - Applied Social Psychology - Psyc...
Sexuality - Issues, Attitude and Behaviour - Applied Social Psychology - Psyc...
 
在线办理(salfor毕业证书)索尔福德大学毕业证毕业完成信一模一样
在线办理(salfor毕业证书)索尔福德大学毕业证毕业完成信一模一样在线办理(salfor毕业证书)索尔福德大学毕业证毕业完成信一模一样
在线办理(salfor毕业证书)索尔福德大学毕业证毕业完成信一模一样
 
Sciences of Europe journal No 142 (2024)
Sciences of Europe journal No 142 (2024)Sciences of Europe journal No 142 (2024)
Sciences of Europe journal No 142 (2024)
 
Modelo de slide quimica para powerpoint
Modelo  de slide quimica para powerpointModelo  de slide quimica para powerpoint
Modelo de slide quimica para powerpoint
 
Randomised Optimisation Algorithms in DAPHNE
Randomised Optimisation Algorithms in DAPHNERandomised Optimisation Algorithms in DAPHNE
Randomised Optimisation Algorithms in DAPHNE
 
Mending Clothing to Support Sustainable Fashion_CIMaR 2024.pdf
Mending Clothing to Support Sustainable Fashion_CIMaR 2024.pdfMending Clothing to Support Sustainable Fashion_CIMaR 2024.pdf
Mending Clothing to Support Sustainable Fashion_CIMaR 2024.pdf
 
Juaristi, Jon. - El canon espanol. El legado de la cultura española a la civi...
Juaristi, Jon. - El canon espanol. El legado de la cultura española a la civi...Juaristi, Jon. - El canon espanol. El legado de la cultura española a la civi...
Juaristi, Jon. - El canon espanol. El legado de la cultura española a la civi...
 
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
 
Gadgets for management of stored product pests_Dr.UPR.pdf
Gadgets for management of stored product pests_Dr.UPR.pdfGadgets for management of stored product pests_Dr.UPR.pdf
Gadgets for management of stored product pests_Dr.UPR.pdf
 
The cost of acquiring information by natural selection
The cost of acquiring information by natural selectionThe cost of acquiring information by natural selection
The cost of acquiring information by natural selection
 
快速办理(UAM毕业证书)马德里自治大学毕业证学位证一模一样
快速办理(UAM毕业证书)马德里自治大学毕业证学位证一模一样快速办理(UAM毕业证书)马德里自治大学毕业证学位证一模一样
快速办理(UAM毕业证书)马德里自治大学毕业证学位证一模一样
 
Authoring a personal GPT for your research and practice: How we created the Q...
Authoring a personal GPT for your research and practice: How we created the Q...Authoring a personal GPT for your research and practice: How we created the Q...
Authoring a personal GPT for your research and practice: How we created the Q...
 
Describing and Interpreting an Immersive Learning Case with the Immersion Cub...
Describing and Interpreting an Immersive Learning Case with the Immersion Cub...Describing and Interpreting an Immersive Learning Case with the Immersion Cub...
Describing and Interpreting an Immersive Learning Case with the Immersion Cub...
 
Micronuclei test.M.sc.zoology.fisheries.
Micronuclei test.M.sc.zoology.fisheries.Micronuclei test.M.sc.zoology.fisheries.
Micronuclei test.M.sc.zoology.fisheries.
 
ESR spectroscopy in liquid food and beverages.pptx
ESR spectroscopy in liquid food and beverages.pptxESR spectroscopy in liquid food and beverages.pptx
ESR spectroscopy in liquid food and beverages.pptx
 
Pests of Storage_Identification_Dr.UPR.pdf
Pests of Storage_Identification_Dr.UPR.pdfPests of Storage_Identification_Dr.UPR.pdf
Pests of Storage_Identification_Dr.UPR.pdf
 
waterlessdyeingtechnolgyusing carbon dioxide chemicalspdf
waterlessdyeingtechnolgyusing carbon dioxide chemicalspdfwaterlessdyeingtechnolgyusing carbon dioxide chemicalspdf
waterlessdyeingtechnolgyusing carbon dioxide chemicalspdf
 
Basics of crystallography, crystal systems, classes and different forms
Basics of crystallography, crystal systems, classes and different formsBasics of crystallography, crystal systems, classes and different forms
Basics of crystallography, crystal systems, classes and different forms
 
The binding of cosmological structures by massless topological defects
The binding of cosmological structures by massless topological defectsThe binding of cosmological structures by massless topological defects
The binding of cosmological structures by massless topological defects
 

HIV

  • 1.
  • 2. HIV/AIDS TREATMENT: ROLE OF DIFFERENT MEDICINAL SYTEM By Mrs. S. Gomathi., M.Pharm., (Ph. D) Assistant Professor Department of Pharmaceutical Chemistry JKK Nattraja College of Pharmacy Kumarapalayam 638183
  • 3.
  • 4. DISTRICT-WISE SCENARIO OF AIDS Category NACP-III A 156 B 39 C 296 D 118 New Districts 30 Total 609 4 Category NACP-III Definition A > 1% ANC prevalence in any of the sites in the last 3 years B < 1% ANC prevalence in all the sites during last 3 years with > 5% prevalence in any HRG site (STD/FSW/MSM/IDU) C < 1% ANC prevalence in all sites during last 3 years with < 5% in all STD clinic attendees or any HRG, with known hot spots D < 1% ANC prevalence in all sites during last 3 years with < 5% in all STD clinic attendees or any HRG OR no or poor HIV data with no known hot spots
  • 5. What is HIV/AIDS? HIV means Human immunodeficiency virus while AIDS means Acquired Immunodeficiency Syndrome –It’s a disease of the human immune system caused by the human immunodeficiency virus (HIV).
  • 6. 6
  • 7. How Do You Get HIV/AIDS?
  • 8. SYMPTOMS AND SIGNS OF HIV The most common symptoms of primary HIV infection are: • fever, • aching muscles and joints, • sore throat and • swollen glands (lymph nodes) in the neck. • Ulcers in the mouth
  • 9. Swollen parts of the body
  • 10. Deterioration of the body tissues
  • 12.
  • 13. TESTING OPTIONS FOR HIV Administration • Blood • Urine • Oral 13
  • 14. BLOOD DETECTION TESTS • Enzyme-Linked Immunosorbent Assay/Enzyme Immunoassay (ELISA/EIA) • Radio Immunoprecipitation Assay/Indirect Fluorescent Antibody Assay (RIP/IFA) • Polymerase Chain Reaction (PCR) • Western Blot Confirmatory test 14
  • 15. URINE TESTING • Urine Western Blot – As sensitive as testing blood – Safe way to screen for HIV – Can cause false positives in certain people at high risk for HIV 15
  • 16. ORAL TESTING • Orasure – The only FDA approved HIV antibody. – As accurate as blood testing – Draws blood-derived fluids from the gum tissue. – NOT A SALIVA TEST! 16
  • 17.
  • 19. CLASSIFICATION OF ANTIRETROVIRAL MEDICINES • NRTI (Nucleoside Reverse Transcriptase Inhibitors) • NtRTI (Nucleotide Reverse Transcriptase Inhibitors) • NNRTI ( Non-Nucleoside Reverse Transcriptase Inhibitors) • PI (Protease Inhibitors) • Other ARVs • Entry Inhibitors: Fusion Inhibitor: Enfuvirtide. Penitration blockrs: Maraviroc • Integrase inhibitors: Raltegravir, Elvitegravir • Maturation inhibitors: Beviramat 19
  • 20. PROTEASE INHIBITORS (PIS) Agent Approved Dose frequency Saquinavir -HGC 12/95 1000mg (500mg) BID Ritonavir 3/96 300mg,600mg BID Indinavir 3/96 800mg TID Nelfinavir 3/97 750mg 1250mg TID BID Saquinavir-SGC 11/97 1000mg BID Lopinavir/ritonavir 9/2000 400mg/100mg BID Atazanavir 6/03 400mg OD Fosamprenavir 10/03 1400mg BID Tipranavir 6/05 500mg BID Darunavir 6/06 600mg BID 20
  • 21. HERBAL DRUGS (AYURVEDHA,SIDDHA)- POSSIBLE ROLE IN TREATMENT OF HIV Withania somifera , Mangifera indica, Allium sativum, Hypericum perforatum. Rasayana reported to exert immunomodulatory effects include Aloe vera, Asparagus racemosus, Boerhavia diffusa, Piper longum. The Non-Rasayana Plants with immunomodulatory effects include Andrographis paniculata, Banksia serrata,Centella asiatica, Curcuma longa and Tamarindus indica.
  • 22. Ayurvedic medicines used for HIV patients include 'Chyavanprash', and 'Raktavardhak' for immunity building and 'Sookshma triphla tabs' to prevent infection.
  • 23. METHODS OF CONTROL Preventive measures: • Refraining from unprotected Intercourse. • Refraining from intravenous drug use. • People who have HIV infection should not donate plasma, blood, organs for transplantation, tissue or cells. • All pregnant women must be counselled about HIV early in pregnancy and encouraged to undertake an HIV test as a routine part of standard antenatal care. • Those found to be HIV-positive take a course of ARV treatment, to reduce the risk of their infant being infected. 23
  • 24. METHODS OF CONTROL (CONT.) • Care must be taken in handling, using and disposing of needles or other sharp instruments. • WHO recommends immunization of asymptomatic HIVinfected children with the EPI vaccines; those who are symptomatic should not receive BCG vaccine. • Live Measles-Mumps-Rubella and polio vaccines are recommended for all HIV-infected children. • HIV testing and counselling is an important intervention for raising awareness of HIV status, promoting behavioural change and diagnosing HIV infection. 24
  • 25. CONCLUSION • HIV/AIDS is a world epidemic. Although making new advances in combating this virus, there are many new infections every year. All should know what how it spreads and how to prevent it. Should take a HIV/AIDS test if involved in any risky behaviors. And also should tell others the importance of getting tested and prevention. • Finally, partnerships between the allopathic and traditional, complementary health sectors in research, policy, and practice are essential in building comprehensive AIDS treatment strategies. Policies that increase the collaboration between these two care sectors should be strongly encouraged. 25
  • 26. REFERENCES Pharmacotherapy, A Pathophysiologic approach by J.T.Dipiro 8 th edition, page.no:2065-2081 emedicine.medscape.com/article/1533218-Author R Chris Rathbun  Aberg, J. A., Kaplan, J. E., Libman, H., "Primary Care Guidelines for the Management of Persons Infected with Human Immunodeficiency Virus: 2009 Update by the HIV Medicine Association of the Infectious Diseases Society of America.  Book of MEDICINE 4th edition, Authors K George Mathew, Praveen Aggarwal, Pg.no.223-234 Anti Retroviral therapy.